AXIM BIOTECHNOLOGIES, INC. Accounts Payable and Other Accrued Liabilities
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Accounts Payable and Other Accrued Liabilities of $1.18 million as of 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2023-05-22
- 2023-03-31: Accounts Payable and Other Accrued Liabilities $1.18M.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities $1.32M.
- 2021-12-31: Accounts Payable and Other Accrued Liabilities $909.46K.
- 2020-12-31: Accounts Payable and Other Accrued Liabilities $1.07M.
| Period end | Accounts Payable and Other Accrued Liabilities |
|---|---|
| 2023-03-31 | $1.18M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $1.32M 10-Q · filed 2023-05-22 |
| 2021-12-31 | $909.46K 10-K · filed 2023-04-17 |
| 2020-12-31 | $1.07M 10-K/A · filed 2022-04-19 |